Form 4 Filing for Edward J. Rapp

This filing details a transaction by Edward J. Rapp, a director at AbbVie Inc. (ABBV). On June 30, 2026, Rapp acquired 134 Stock Equivalent Units, with a transaction value of $251.64 per unit. These units were acquired under a director fee plan, where fees are credited to a stock equivalent unit account and distributed over years of board service, commencing at age 65 or upon retirement. The units earn returns as if invested in AbbVie stock. Following this acquisition, Rapp holds 29,236 Stock Equivalent Units. The balance includes units acquired through a dividend reinvestment feature. The transaction was reported on July 2, 2026.